| 摘要 |
Utility model patent to TRAXNOX, which is a fungicide resulting from the mixture of methyl(2E)-2-(2-{[6-(2-cyanophenoxy)pyrimidin-4-yl]oxy}phenyl)-3-methoxyacrylate and 2RS,3RS,2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol. The invention pertains to the chemical groups of the systemic products strobilurin and triazole, with a dose of 0.4L/ha and a volume of 300L/ha. Its particular feature is that it exterminates phytopathogenic fungi, according to strict reliability standards, since it degrades slowly and when decomposed, the subproducts thereof are toxic for the pathogen; it does not affect the host plant; and it is essential for managing the disease in large area cultures. The TRAXNOX fungicide has a fungicidal effect within 72 hours. It has an effective preventive action, since it inhibits the development of the pathological syndrom in the plant when applied after pathogen invasion; it prevents the appearance of pustules, which are phytopathogenic fungi structures. It has a therapeutic action confined to the post-infection and presymptomatic phases, it dries out and eradicates the pustules, eliminating all spores, and acts as an eradicant, word which describes the effects in the post-symptomatic stages, in which it exterminates the Puccinia psidii fungi present on Eucalyptus sp..
|
